• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结受累作为前列腺癌患者的预后指标。

Nodal involvement as a prognostic indicator in patients with prostatic carcinoma.

作者信息

Prout G R, Heaney J A, Griffin P P, Daly J J, Shipley W U

出版信息

J Urol. 1980 Aug;124(2):226-31. doi: 10.1016/s0022-5347(17)55382-3.

DOI:10.1016/s0022-5347(17)55382-3
PMID:7401236
Abstract

Between 1969 and 1976, 92 patients with proved prostatic carcinoma in stages T0 and T4 underwent pelvic lymphadenectomy. Median followup has been 43 months. All patients had normal serum acid phosphatase levels and no clinical evidence of metastases as determined by physical examination, bone scans and metastatic bone surveys. Pelvic lymph node metastases were noted in 32 cases. Radical prostatectomy was done in 34 cases and 45 patients received radiotherapy, 11 of whom had 125iodine seeds implanted. Progression of the neoplastic process, almost exclusively in the form of bony metastases, occurred in 18 of the 32 patients who had positive pelvic nodes and in 6 of the 60 patients with negative nodes (p less than 0.001). Patients with poorly differentiated carcinoma were more likely to have progression of the disease than those with moderately differentiated carcinoma (p less than 0.01) and no patient with a well differentiated carcinoma had disease progression.

摘要

1969年至1976年间,92例经证实为T0期和T4期前列腺癌的患者接受了盆腔淋巴结清扫术。中位随访时间为43个月。所有患者血清酸性磷酸酶水平均正常,且经体格检查、骨扫描和转移性骨检查未发现临床转移证据。32例发现盆腔淋巴结转移。34例行根治性前列腺切除术,45例患者接受放疗,其中11例植入了125碘籽源。在32例盆腔淋巴结阳性的患者中,18例出现肿瘤进展,几乎均为骨转移形式;在60例盆腔淋巴结阴性的患者中,6例出现肿瘤进展(p<0.001)。低分化癌患者比中分化癌患者更易出现疾病进展(p<0.01),而高分化癌患者无疾病进展。

相似文献

1
Nodal involvement as a prognostic indicator in patients with prostatic carcinoma.淋巴结受累作为前列腺癌患者的预后指标。
J Urol. 1980 Aug;124(2):226-31. doi: 10.1016/s0022-5347(17)55382-3.
2
[Prostatic adenocarcinoma: nodal involvement and prognosis of stage D1 patients].[前列腺腺癌:D1期患者的淋巴结受累情况及预后]
Hinyokika Kiyo. 1989 Jun;35(6):981-6.
3
Risk of prostate carcinoma death in patients with lymph node metastasis.有淋巴结转移的患者发生前列腺癌死亡的风险。
Cancer. 2001 Jan 1;91(1):66-73. doi: 10.1002/1097-0142(20010101)91:1<66::aid-cncr9>3.0.co;2-p.
4
Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.根治性膀胱切除术和扩大盆腔淋巴结清扫术:仅接受手术治疗的髂总血管分叉以上淋巴结转移患者的生存率。
J Urol. 2007 Oct;178(4 Pt 1):1218-23; discussion 1223-4. doi: 10.1016/j.juro.2007.05.160. Epub 2007 Aug 14.
5
Prognostic factors in lymph node metastases of prostatic cancer patients: the size of the metastases but not extranodal extension independently predicts survival.前列腺癌患者淋巴结转移的预后因素:转移灶大小而非结外扩展独立预测生存率。
Histopathology. 2008 Oct;53(4):468-75. doi: 10.1111/j.1365-2559.2008.03129.x. Epub 2008 Sep 1.
6
Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?根治性前列腺切除术后淋巴结阳性患者的疾病进展与生存情况。是否存在治愈的机会?
J Urol. 2003 Mar;169(3):849-54. doi: 10.1097/01.ju.0000049032.38743.c7.
7
Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.膀胱癌盆腔淋巴结转移:83例患者根治性膀胱切除及盆腔淋巴结清扫后的结局
J Urol. 2001 Jul;166(1):19-23.
8
[Staging pelvic lymphadenectomy for carcinoma of the prostate: review of 23 cases].
Hinyokika Kiyo. 1986 Mar;32(3):401-6.
9
Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.接受根治性前列腺切除术患者的扩大盆腔淋巴结清扫术:淋巴结转移发生率高。
J Urol. 2002 Apr;167(4):1681-6.
10
Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma.盆腔淋巴结清扫术作为前列腺癌确定性治疗前的分期手段。
Scand J Urol Nephrol Suppl. 1988;110:155-61.

引用本文的文献

1
Node dissection in prostate cancer: no answers for old questions.前列腺癌中的淋巴结清扫:旧问题仍无答案。
Int Braz J Urol. 2022 Jan-Feb;48(1):67-69. doi: 10.1590/S1677-5538.IBJU.2021.1063.1.
2
The Quantitative Criteria Based on the Fractal Dimensions, Entropy, and Lacunarity for the Spatial Distribution of Cancer Cell Nuclei Enable Identification of Low or High Aggressive Prostate Carcinomas.基于分形维数、熵和空隙率的癌细胞核空间分布定量标准能够识别低侵袭性或高侵袭性前列腺癌。
Front Physiol. 2016 Feb 11;7:34. doi: 10.3389/fphys.2016.00034. eCollection 2016.
3
Urology-important advances in clinical medicine: computerized tomography, lymphangiography and Gleason scores for staging prostatic adenocarcinoma.
泌尿学——临床医学的重要进展:计算机断层扫描、淋巴管造影术以及前列腺腺癌分期的 Gleason 评分
West J Med. 1983 Apr;138(4):555-6.
4
Prostate Cancer Old Problems and New Approaches. Part III. Prevention and Treatment.前列腺癌:老问题与新方法。第三部分。预防与治疗。
Pathol Oncol Res. 1996;2(4):276-292. doi: 10.1007/BF02904824.
5
[The conformal radiotherapy of localized prostatic carcinoma: acute tolerance and early efficacy].
Strahlenther Onkol. 1997 Feb;173(2):98-105. doi: 10.1007/BF03038929.
6
Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma.香豆素(1,2-苯并吡喃酮)用于治疗前列腺癌。
J Cancer Res Clin Oncol. 1994;120 Suppl(Suppl 1):S35-8. doi: 10.1007/BF01377123.
7
Assessment of the regional lymph node status in radiation monotherapy of prostatic cancer.前列腺癌放射单疗法中区域淋巴结状态的评估
Int Urol Nephrol. 1986;18(1):75-84. doi: 10.1007/BF02082652.
8
The metastatic potential of prostate carcinomas composed entirely of single malignant glands.完全由单个恶性腺管构成的前列腺癌的转移潜能。
Virchows Arch A Pathol Anat Histopathol. 1987;411(5):399-402. doi: 10.1007/BF00735219.